baber/WOPTO huggingface dataset:
Patent FI-942666-A0 (FI)
Inventor: HEISKARI MIKA
IPC: H04W84/08
Filed: 1994-06-06
Abstract: PCT No. PCT/FI95/00318 Sec. 371 Date Feb. 5, 1996 Sec. 102(e) Date Feb. 5, 1996 PCT Filed Jun. 5, 1995 PCT Pub. No. WO95/34179 PCT Pub. Date Dec. 14, 1995A method for reacting to disturbance on an uplink frequency in a mobile communication system which comprises a mobile communication network which includes at least one base station and a mobile services switching center, as well as at least one mobile station which communicates with base station on an uplink, i.e. receive, frequency, and on a downlink, i.e. transmit, frequency of base station. In order to react advantageously to an uplink disturbance, the following procedure will be followed: a mobile communication network detects the disturbance on an uplink frequency, the mobile communication network informs a mobile station of disturbance by using a downlink frequency and commands the mobile station to listening mode in which the mobile station stays on the same downlink frequency and receives information from the base station, the mobile station shifts to listening mode.
Patent FI-943501-A0 (FI)
Inventor: RASMUSSEN OLE-BENDT
IPC: B32B7/02
Filed: 1994-07-25
Abstract: PCT No. PCT/GB93/00177 Sec. 371 Date Jun. 16, 1994 Sec. 102(e) Date Jun. 16, 1994 PCT Filed Jan. 28, 1993 PCT Pub. No. WO93/14928 PCT Pub. Date Aug. 5, 1993A cross-laminate of two or more individually stretch oriented films where the directions of orientation of the films are in criss-crossing relation, has a pattern of generally parallel elongated ribs extending lengthwise of the laminate. The ribs are defined between generally transversely coincident convex and concave curved surfaces on opposite faces of the laminate, the concave surface having a radius of curvature greater than that of the convex surface so that the ribs have a thickness greater than the average thickness of the laminate. The laminate material adjacent to lateral boundaries of the ribs is in a tensionless state reversely curved relative to the rib curvature making the material between adjacent pairs of ribs generally flat. The rib pattern is preferably regular with a preferred average transverse spacing between adjacent ribs, measured peak to peak, of about 1-10 mm. The convex surfaces of the ribs can all be on the same side of the laminate or can alternate in series between opposite sides. The pattern of elongated ribs can be interrupted at longitudinally spaced loci to enhance the flexibility of the laminate and the laminate can have an undulating curvature when viewed from the side. A process and apparatus for making the ribbed cross-laminate by means of intermeshing grooved rollers are also disclosed.
Patent FI-945769-A0 (FI)
Inventor: VICIK STEPHEN JAMES
IPC: B32B27/28
Filed: 1994-12-08
Abstract: A biaxially stretched oriented heat shrinkable film for food packaging comprising an EVOH-nylon 6,66 core layer, second and third intermediate adhesive layers, a self heat sealable fourth outer layer and an abuse-resistant fifth outer layer.
Patent FI-946090-A0 (FI)
Inventor: YLAE-OUTINEN PETTERI
IPC: H04W4/16
Filed: 1994-12-23
Abstract: PCT No. PCT/FI95/00704 Sec. 371 Date Jun. 20, 1997 Sec. 102(e) Date Jun. 20, 1997 PCT Filed Dec. 21, 1995 PCT Pub. No. WO96/20554 PCT Pub. Date Jul. 4, 1996A mobile services switching center for forwarding a subscriber directory number terminating call to a call forwarding number which is retrieved from a separate subscriber database. The mobile services switching center contains a call forwarding database which stores directory numbers of forwarding parties from each of which a set-up of a forwarded call is in progress. The call control of the mobile services switching center is arranged to check, prior to initiating call forwarding, whether a directory number of the forwarding party is included in the call forwarding database. The call control of the mobile services switching center is further arranged to release the call in response to the directory number of the forwarding party being included in the call forwarding database, in order to avoid looping of the call due to the call forwarding, and, in response to the directory number of the forwarding party not being included in the call forwarding database, to insert the directory number of the forwarding party in the call forwarding database, and to continue the call forwarding.
Patent FI-953878-A0 (FI)
Inventor: HODGEN GARY D
IPC: A61K31/565
Filed: 1995-08-17
Abstract: The use of a progesterone receptor antagonist for the preparation of a pharmaceutical composition for preventing an oocyte from becoming fertilized without preventing ovulation or interfering with the regularity of the ovarian menstrual cycle of a mammal. <IMAGE>
Patent FI-972953-A0 (FI)
Inventor: LEVY JULIA
IPC: A61K41/00
Filed: 1997-07-11
Abstract: A method for reducing the rejection of allografts comprising donor tissue containing antigen presenting cells (APC's), which method comprises: a) contacting the donor tissue with a photosensitizing agent to obtain a modified donor tissue; b) exposing the modified donor tissue to light having a wavelength absorbed by the photosensitizing agent for a time sufficient to deplete the APC's in the donor tissue; and c) transplanting the APC-depleted donor tissue into the tissue of a recipient. By subjecting donor tissue to photodynamic therapy, the mean survival time of grafts, particularly skin allografts, was significantly lengthened. The photosensitizer may also be part of a conjugate containing a target-specific moiety.
Patent FI-974385-A0 (FI)
Inventor: VARGAS MUNITA SERGIO LUIS
IPC: A61K9/00
Filed: 1997-12-01
Abstract: The invention relates to the use of polyols such as xylitol for the preparation of a composition to be administered in the treatment or prophylaxis of mucosal yeast infection in mammals, as well as to preparations for use in the systemic or topical therapeutic or prophylactic treatment of mucosal yeast infections. The invention relates specifically but not solely to the combating of infections caused by Candida s.p. in mucosa in connection with exocrine glands of the mammalian body.
Patent FI-980968-A0 (FI)
Inventor: VUORINEN TAPANI
IPC: D21C9/00
Filed: 1998-04-30
Abstract: The present invention relates to a modified fiber product and a method of producing same. According to the method, the cellulosic raw material is formed into a fiber suspension, into which components modifying the properties of the fibers are added, subsequent to which the fibrous material is dried in connection with, for example, web forming. According to the invention, alkyl derivative of cellulose is mixed into the fiber suspension in alkaline conditions, the derivative being at least partly dissolved in water, and the derivative is allowed to be sorbed into the fibrous material prior to drying such that the sorbed cellulose derivative can not be washed off with water. The strength properties or the water retention of paper and paperboard products can be improved by using the invention.
Patent IL-63648-A0 (IL)
Title: Azolylalkyl derivatives,their preparation and their use as fungicides
IPC: A01N43/653
Filed: 1981-08-24
Abstract: Fungicidally active novel azolylalkyl derivatives of the formula <IMAGE>   in which R1 is an alkyl or aryl group, R2 is a hydrogen atom or an alkyl or aryl group, R3 is cyano or -CO-OR4, R4 is alkyl or aralkyl group, A is a keto group or a CH(OH) group, X is a nitrogen atom or the CH group, and m and n are identical and represent 0 to 1, or a physiologically acceptable addition product thereof with an acid or a metal salt.
Patent IL-63650-A0 (IL)
Title: Heat exchanger having a plurality of vertical pipes for upward passage of a first heat-exchanging medium
IPC: F28G1/12
Filed: 1981-08-24
Abstract: Heat exchanger having a plurality of vertical pipes for upward passage of a first heat-exchanging medium, at least one compartment for passage of a second heat-exchanging medium through which compartment said pipes extend, a lower chamber through which said first medium passes and into which said pipes open for admission to the pipes of said first medium, and a flow distribution element adapted to distribute the flow of said first medium in said lower chamber to the pipes. A fluidizable particulate material is in operation, is maintained in a fluidized state in the pipes by the flow of the first medium. The pipes have inlet elements extending downwardly into said lower chamber with their lowermost ends open. Stabilization openings are provided into said inlet elements above said open lowermost ends thereof. To prevent blocking of the stabilization openings by dirt, these are separated, outside the inlet elements, from the said open lowermost ends of the inlet elements by at least one screen which allows flow of the first medium to the stabilization openings.
Patent IL-74884-A0 (IL)
Title: High flux membrane
IPC: B01D67/00
Filed: 1985-04-11
Abstract: PCT No. PCT/AU85/00078 Sec. 371 Date Dec. 6, 1985 Sec. 102(e) Date Dec. 6, 1985 PCT Filed Apr. 10, 1985 PCT Pub. No. WO85/04593 PCT Pub. Date Oct. 24, 1985.The instant invention provides a semipermeable membrane having a maximized porosity with surface properties providing enhanced flux, and good chemical resistance.
Patent IL-78529-A0 (IL)
Title: Modification of the dna sequence between the shine-dalgarno sequence and the start codon of the trp-operon to increase protein expression
IPC: C12R1/19
Filed: 1986-04-17
Abstract: For the contracting states : BE, CH, DE, GB, IT, LI, LU, NL, SE 1. DNA segment of the trp operon from E. coli, characterized by the sequence (coding strand) I 5' CTATCGACC 3' (I) which is connected at the 5' end to the Shine-Dalgarno sequence AAGG, and at the 3' end to the start codon ATG. For the contracting state : AT 1. A process for the preparation of a vector having the trp expression system of E. coli, characterized by cleavage with the restriction enzyme Nco l of an E. coli vector which contains the DNA sequence I 5' GTATCGACC 3' (I) (coding strand) followed by 5' ATGG 3', and a) ligation of a gene structure of DNA sequence II 5' CATG X... 3' 3'      Y... 5' (II) in which X and Y denote the first complementary pair of nucleotides downstream of the start codon of a structural gene, in the cleavage site, or b) enzymatic filling in of the cleavage site and ligation of the DNA of the sequence III 5' GTA TCG ACC ATG 3' (III) 3' CAT AGC TGG TAC 5' with a DNA of the sequence IV 5' X... 3' (IV) 3' Y... 5' in which X and Y have the abovementioned meaning, or c) enzymatic degradation of the protruding sequence of the cleavage site, and ligation of the DNA of the sequence VI 5' GTA TCG AC 3' (VI) 3' CAT AGC TG 5' with a DNA of the sequence VII 5' Z ATG X... 3' (VII) 3' Z'TAC Y... 5' Z and Z' denoting any desired pair of nucleotides, which can also be dispensed with.
Patent IL-89303-A0 (IL)
Title: Cephalosporin derivatives and processes for their preparation
IPC: A61K31/546
Filed: 1989-02-15
Abstract: Cephemcarboxylic acid esters of the general formula   <IMAGE>  +TR   <IMAGE>   pharmaceutical preparations which are active against bacterial infections, which contain such cephem derivatives, a process for the preparation of the cephem derivatives and the pharmaceutical preparations, and also the use of the cephem derivatives for combating bacterial infections.
Patent IL-91720-A0 (IL)
Title: Method of thermo-forming a novel matrix composite body and products produced therefrom
IPC: C22C21/00
Filed: 1989-09-21
Abstract: The present invention relates to the formation of a metal matrix composite body by a spontaneous infiltration technique and thereafter thermo-forming the produced metal matrix composite body. Particularly, an infiltration enhancer and/or an infiltration enhancer precursor and/or an infiltrating atmosphere are in communication with a filler material (2) or a preform, at least at some point during the process, which permits molten matrix metal to spontaneously infiltrate the filler material (2) or preform. After formation of the metal matrix composite body, the body is subjected to a thermo-forming technique such as rolling, extruding, die casting, pressing, etc.
Patent IL-96245-A0 (IL)
Title: Process for the preparation of lewis acid-based catalyst fluorinated aromatic derivatives
IPC: B01J21/04
Filed: 1990-11-05
Abstract: Process for the preparation of aryl fluoride by bringing a gaseous mixture containing hydrofluoric acid and an aryl haloformate or carbonate into contact with a catalyst based on Lewis acids.
Patent IL-98428-A0 (IL)
Title: Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IPC: A61K31/495
Filed: 1991-06-10
Abstract: New heterocyclic compounds having general formula (I), wherein R<3> is (a), or (b), wherein R' is H, C1-6-alkyl or C3-7-cycloalkyl; -B- is -C(R'')=N- or -N=C(R'')-. Or, wherein R'' is a cyclic amine or -NR'''R'''', wherein R''' and R'''' independently are H, C1-6-alkoxy, C3-7-cycloalkyl or C1-6-alkyl. The compounds are useful in psychoparmaceutical preparations as anticonvulsants, anxiolytics, hypnotics and in improving the cognitive function of the brain of mammals.
Patent AU-PR224300-A0 (AU)
Title: An apparatus (mj72)
IPC: B41J2/155
Filed: 2000-12-21
Abstract: A pagewidth printhead for an inkjet printer includes an elongate support; a plurality of printhead modules supported by the support, each printhead module comprising rows of unit cells, each unit cell comprising a nozzle through which ink is ejected and an actuator for ejecting ink from the nozzle; and an engagement mechanism having complementary formations defined on opposite edges of each printhead module to engage the printhead modules together in series along the support. The engagement mechanism includes a biasing means configured to press the serially arranged printhead modules together, the biasing means including at least one compression spring. A gap is defined between the unit cells of adjacent printhead modules, the gap extending obliquely with respect to the support.
Patent FI-20050715-A0 (FI)
Inventor: SALOVAARA HANNU
IPC: A23L7/104
Filed: 2005-07-04
Abstract: The present invention relates to a stabile cereal-based food suspension that has been prepared by a) heat-treating a mixture of beta- glucan-rich cereal material and water to gelatinize the starch contained in the cereal material to form a suspension; b) by cooling the heat-treated suspension; and c) by grinding the cooled suspension to form a stabile food suspension, the food suspension having a beta-glucan concentration of at least 0.25 g/100 g of food suspension. Further, the invention concerns a method for preparing a food suspension, as well as use of a food suspension.
Patent IL-109587-A0 (IL)
Title: Purified heparin fractions, method for obtaining them and pharmaceutical compositions containing them
IPC: C08B37/00
Filed: 1994-05-06
Abstract: Heparin fractions obtained by nitrous depolymerisation, containing not more than 150 ppb of total nitroso compounds, prepared by subjecting heparins depolymerised by using a nitrite to the action of UV radiation.
Patent IL-109975-A0 (IL)
Title: N-[[1-[4-(4- fluorophenoxy) butyl]- 4-piperidinyl] -n-methylamino]-2-benzothiazolols, their preparation and pharmaceutical compositions containing them
IPC: C07D277/12
Filed: 1994-06-10
Abstract: PCT No. PCT/EP94/01849 Sec. 371 Date Nov. 16, 1995 Sec. 102(e) Date Nov. 16, 1995 PCT Filed Jun. 6, 1994 PCT Pub. No. WO94/29305 PCT Pub. Date Dec. 22, 19942-[[1-[4-(4-fluorophenoxy)butyl]-4-piperidinyl]methylamino]-benzothiazololes    <IMAGE>  (I)  variable always being hydrogen, and the pharmaceutically acceptable acid addition salts thereof. Novel compounds, pharmaceutical compositions, as well as their use as a class III antiarrhythmicum is disclosed.
Patent IL-128205-A0 (IL)
Title: Potassium channel inhibitors and pharmaceutical compositions containing the same
IPC: A61P9/00
Filed: 1997-07-23
Abstract: Compounds useful as potassium channel inhibitors and especially useful for the treatment of cardiac arrhythmias and cell proliferative disorders are described.
Patent IL-128931-A0 (IL)
Title: Tricylic antitumor compounds being farnesyl protein transferase inhibitors
IPC: A61K31/4545
Filed: 1997-09-11
Abstract: The invention relates to tricyclic compounds of formula (1.0) wherein R<1>, R<2>, R<3>, R<4>, R<5>, R<6>, R<7>, R<8>, Y, A, B, X, a, b, c, d, v, and w are as described herein. The compounds of formula (1.0) are useful for inhibiting tumor growth being farnesyl protein transferase inhibitors.
Patent IL-133831-A0 (IL)
Title: Pharmaceutical compositions containing proteasome inhibitors
IPC: C07D471/04
Filed: 1999-12-30
Abstract: Disclosed herein are novel boronic ester and acid compounds, their synthesis and their uses.
Patent IL-136557-A0 (IL)
Title: A method and an apparatus for separation of foremilk
IPC: A01J5/017
Filed: 1998-12-21
Abstract: The present invention relates to a method for automatic separation of foremilk and/or milk not suitable for consumption from the milk line system of a milking plant and an apparatus for carrying out said method. A separating device (44) is arranged at the ends of a milk line (52) and a test milk line (56), said milk lines being parallel. The separating device is designed with a damper means (48) attached to a cup (46). When milk is fed through the outlet (16), the cup (46) is filled up and its weight pivots the separating device from a first position, in which the inlet to a milk line (52) is closed by means of the damper mean, to a second position, in which the milk in cup is poured into a test milk line (56) and the damper means is lifted off the inlet (50|) to the milk line (52).
Patent IL-164569-A0 (IL)
Title: Cetp activity inhibitor
IPC: C07C323/63
Filed: 2004-10-14
Abstract: The present invention provides a CETP activity inhibitor comprising as an active ingredient a compound represented by the formula (I):   
wherein R represents a straight chain or branched alkyl group; a straight chain or branched alkenyl group; a lower haloalkyl group; a substituted orunsubstituted cycloalkyl group; a substituted or unsubstituted cycloalkenyl group; a substituted or unsubstituted cycloalkylalkyl group; a substituted or unsubstituted aryl group, or a substituted or unsubstituted heterocyclic group, X 1 , X 2 , X 3 , and X, may be the same or different and each represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower haloalkyl group; a lower alkoxy group; a cyano group; a nitro group; an acyl group; or an aryl group, Y represents -CO- or -SO 2 -, and Z represents a hydrogen atom or a mercapto-protecting group, or a prodrug compound, a pharmaceutically acceptable salt, or hydrate or solvate thereof. The compounds represented by the formula (I) can increase HDL and at the same time decrease LDL through selective inhibition of CETP activity and, therefore, is expected to be useful as a new type of a preventive or therapeutic agent for atherosclerosis or hyperlipidemia.
Patent IL-173336-A0 (IL)
Title: Therapeutic compounds
IPC: A61K31/5517
Filed: 2006-01-24
Abstract: The invention relates to trycyclic lactam indole derivatives and triacyclic lactam benzimodole derivatives and their use in inhibiting the activity of PARP enzyme. The invention also relates to the use of these compounds in the preparation of medicaments.
Patent IL-178746-A0 (IL)
Title: Methods for treatment of lung cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
IPC: A61P9/00
Filed: 2006-10-19
Abstract: Methods of treating, preventing and/or managing cancer as well as diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Patent IL-180473-A0 (IL)
Title: Method and systems for providing an infusion device interface
Filed: 2007-01-01
Abstract: An infusion device (100) comprising an infuser base (105), a cannula (115), a ferrule (120) and an elastomeric septum (140).
Patent IL-207359-A0 (IL)
Title: Method and apparatus for providing multiple quality of service levels in a wireless packet data services connection
IPC: H04W76/02
Filed: 2010-08-02
Abstract: The packets generated by each of multiple packet data applications are provided to a single Point-to-Point Protocol (PPP) stack and a single High-level Data Link Control (HDLC) framing layer to convert data packets into byte streams suitable for transmission through Radio Link Protocol (RLP) connections. Each of the resultant multiple byte streams is then provided to one of multiple RLP connections having different retransmission and delay properties. The RLP connection selected for sending data from each application is based on the grade of service most appropriate for the application. At the receiver, the data from the multiple RLP connections is provided to a single PPP stack.
Patent RO-128864-A0 (RO)
Title: Installation for testing turbine blades with hydrogen flame adjustment
Inventor: MATACHE GHEORGHE
IPC: G01M15/00
Filed: 2013-04-08
Abstract: The installation relates to an installation for testing turbine blades with hydrogen flame adjustment which is used in the field of research and production of gas turbine blades and in the thermogasodynamic field with biphase combustion. According to the invention, the installation comprises an experimental section (3) which has a self-contained turbine stator assembly (4) and a self-contained turbine rotor blade assembly (5), which has placed in the centre an experimental rotor blade (10) being attached to the turbine rotor blade assembly (5) by means of a pine cone system, and by screwing and an elastic sealing system to a drawbar (14) supported integrally on the experimental section (3) by means of a framework (15), a part of the cooling air being directed through a pipe (16) for adjusting the temperature lengthwise the experimental rotor blade (10), introducing hydrogen through an adjustable throttle system (21), further on the hydrogen being distributed through some pipes (22) and cylindrical grooves (f) cut in the turbine stator blade (6), the hydrogen coming out out through some holes (g) on the leading edge of the turbine stator blade (6).
Patent RO-137260-A0 (RO)
Title: Methods for establishing a set of parameters for in-vitro model assessment of the biosafety, antioxidant and anti-inflammatory capacity of a bioproduct of fermented polyfloral pollen
Inventor: POP SEVINCI
IPC: G01N33/533
Filed: 2022-08-29
Abstract: The invention relates to a method for assessing the biosafety and the antioxidant and anti-inflammatory capacity of a bioproduct of fermented polyfloral pollen. According to the invention, the method consists of the following steps: assessing cell viability and proliferation on in-vitro models of human cell lines (monocytes, normal and tumoural liver cells) with the MTS kit, measuring the cytotoxicity induced by the bioproduct with the LDH kit, determining the cellular antioxidant capacity, and the capacity to modulate cytokine expression in in vitro models, resulting in a set of parameters of the analysed bioproduct suitable for its use as a therapeutic product or as an active substance in dietary supplements.